TLX vs GE

For growth investors, Telix Pharmaceuticals Limited (TLX) is the stronger pick with 55.

8% revenue growth year-over-year, versus 18. 5% for GE Aerospace (GE). GE Aerospace (GE) offers the better valuation at 37. 1x trailing P/E (40. 0x forward), making it the more compelling value choice. Analysts rate Telix Pharmaceuticals Limited (TLX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, GE Aerospace (GE) is the cheapest at 37.

1x versus Telix Pharmaceuticals Limited at 105. 1x. On forward P/E, GE Aerospace is actually cheaper at 40. 0x.

Over the past 5 years, GE Aerospace (GE) delivered a total return of +362.

5%, compared to -29. 6% for Telix Pharmaceuticals Limited (TLX). Over 10 years, the gap is even starker: GE returned +121. 0% versus TLX's -29. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Telix Pharmaceuticals Limited (TLX) is the lower-risk stock at 0.

89β versus GE Aerospace's 1. 14β — meaning GE is approximately 29% more volatile than TLX relative to the S&P 500. On balance sheet safety, Telix Pharmaceuticals Limited (TLX) carries a lower debt/equity ratio of 102% versus 108% for GE Aerospace — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Telix Pharmaceuticals Limited (TLX) is pulling ahead at 55.

8% versus 18. 5% for GE Aerospace (GE). On earnings-per-share growth, the picture is similar: Telix Pharmaceuticals Limited grew EPS 769. 6% year-over-year, compared to 36. 2% for GE Aerospace. Over a 3-year CAGR, TLX leads at 368. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

GE Aerospace (GE) is the more profitable company, earning 19.

0% net margin versus 6. 4% for Telix Pharmaceuticals Limited — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GE leads at 19. 1% versus 10. 5% for TLX. At the gross margin level — before operating expenses — TLX leads at 65. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, GE Aerospace (GE) trades at 40.

0x forward P/E versus 168. 7x for Telix Pharmaceuticals Limited — 128. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TLX: 59. 5% to $17. 00.

In this comparison, GE (0.

4% yield) pays a dividend. TLX does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Telix Pharmaceuticals Limited (TLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

89)). Both have compounded well over 10 years (TLX: -29. 6%, GE: +121. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (TLX (Healthcare) and GE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.